Search for Clinical Trial Results

Sponsored By

Haemophilus Influenzae - 20 Studies Found

Status Study
Recruiting Study Name: Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried
Condition: Haemophilus Influenzae Type b Infections
Date: 2015-09-19
Interventions:
  • Biological: Minhai-HIB 0.5ml,

Completed Study Name: Nontypeable H. Influenzae in Healthy Adults
Condition: Haemophilus Influenzae (NTHI)
Date: 2009-05-18
Interventions: Biological: NTHi Strain 2019 Nontypeable Haemophilus influenzae (NTHi) strain 2019 StrR Number 1 is an a
Completed Study Name: Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
Condition: Haemophilus Influenzae Type b
Date: 2008-08-12
Interventions: Biological: Haemophilus influenzae type b 1 dose monovalent conjugated vaccine against Haemophilus influ
Completed Study Name: Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b
Condition: Haemophilus Influenzae Type b
Date: 2008-12-12
Interventions:
  • Biological: Haemophilus influenzae type b vaccine

Completed Study Name: Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children
Condition: Haemophilus Influenzae Type B Infection
Date: 2011-07-25
Interventions: Biological: Haemophilus influenza type b conjugate vaccine Primary series is 3 doses given to infants be
Completed Study Name: Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China
Condition: Haemophilus Influenzae Type b (Hib) Infection
Date: 2010-01-03
Interventions: Biological: Haemophilus influenzae type b (Hib) vaccine Comparator study of two commercially available H
Completed Study Name: Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults
Condition:
  • Diseases Caused by Streptococcus Pneumoniae and Nontypable Haemophilus Influenzae
  • Date: 2008-12-23
    Interventions:
    • Biological: GSK2231395A Two do
Completed Study Name: Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)
Condition:
  • Haemophilus Influenzae Type B
  • Hepatitis B

Date: 2007-02-26
Interventions:
  • Biological: Comparator: Modified Process Vaccine

Completed Study Name: Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children
Condition: Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b
Date: 2014-05-13
Interventions:
  • Biological: Hib-CRM197 No vacc
Terminated Study Name: Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine
Condition:
  • Haemophilus Influenzae
  • Streptococcus Pneumoniae

Date: 2009-02-19
Interventions:
  • Biological: GSK2231395A 3 dose
Next >>>